-+ 0.00%
-+ 0.00%
-+ 0.00%

LAKEWOOD-AMEDEX BIOTHERAPEUTICS ANNOUNCES AGREEMENT WITH PERI TO SERVE AS CRO FOR PHASE 2 CLINICAL TRIAL OF NU-3

Reuters·05/12/2026 12:02:00

Please log in to view news